Pharmaceutical Stocks Worth Watching – June 30th

by · The Cerbat Gem

Eli Lilly and Company, Thermo Fisher Scientific, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares of companies that research, develop, manufacture and market prescription drugs and therapeutic treatments. Investors buy these stocks to gain exposure to the healthcare and biotech sectors, hoping to profit from successful drug approvals and patent protections while bearing risks such as clinical-trial failures, regulatory setbacks and patent expirations. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY stock traded up $0.59 on Monday, reaching $776.04. The company had a trading volume of 1,198,633 shares, compared to its average volume of 3,674,033. The stock has a market cap of $735.48 billion, a PE ratio of 63.14, a PEG ratio of 1.13 and a beta of 0.41. The company has a 50-day moving average of $780.19 and a 200-day moving average of $800.08. The company has a current ratio of 1.37, a quick ratio of 1.06 and a debt-to-equity ratio of 2.18. Eli Lilly and Company has a 12 month low of $677.09 and a 12 month high of $972.53.

Read Our Latest Research Report on LLY

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of TMO stock traded down $5.82 during trading on Monday, reaching $402.46. The company’s stock had a trading volume of 1,574,016 shares, compared to its average volume of 1,950,761. The business has a fifty day moving average price of $409.74 and a 200-day moving average price of $482.94. Thermo Fisher Scientific has a one year low of $385.46 and a one year high of $627.88. The company has a quick ratio of 1.38, a current ratio of 1.77 and a debt-to-equity ratio of 0.64. The company has a market cap of $151.92 billion, a price-to-earnings ratio of 23.60, a price-to-earnings-growth ratio of 2.17 and a beta of 0.78.

Read Our Latest Research Report on TMO

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Shares of Pfizer stock traded up $0.02 during trading on Monday, reaching $24.21. 22,684,629 shares of the company traded hands, compared to its average volume of 41,302,762. The firm has a market capitalization of $137.64 billion, a PE ratio of 17.54, a P/E/G ratio of 0.88 and a beta of 0.57. The company has a 50 day moving average price of $23.46 and a 200-day moving average price of $24.84. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.26 and a quick ratio of 0.96. Pfizer has a 1-year low of $20.92 and a 1-year high of $31.54.

Read Our Latest Research Report on PFE

Further Reading